Neuro-Oncology Program at H. Lee Moffitt Cancer Center

Contents

• Location

• Physicians

• NABTT Protocol Availability

• Contact Information

Location

H. Lee Moffitt Cancer Center
12902 Magnolia Drive
Tampa, FL 33612

NABTT Protocol Availability

• Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults with Newly Diagnosed Malignant Glioma

• A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant and Adjuvant Temozolomide with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme
• A Phase II Trial of Talampanel in Conjunction with Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme

Class C: (Recurrent High Grade Astrocytoma, with Measurable Disease)

• A Phase I/II Trial of BMS-247550 for Treatment of Patients with Recurrent High-grade Gliomas

• A Phase I, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients with MTAP-Deficient High Grade Recurrent Malignant Gliomas

• A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Glioma

Class E: (Histology other than High Grade Astrocytoma)

• A Phase II Study of Anti-CD20 Monoclonal Antibody (Rituximab) Therapy for Patients with Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Class F: (Non "Therapeutic" Protocols)

• A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas

• CD4 Count and Risk of Infection in Patients with Brain Tumors

For information regarding the protocols available at this center, please contact:

Shirley Entis, RN

Clinical Trials Coordinator
H. Lee Moffitt Cancer Center
12902 Magnolia Drive
Tampa, FL 33612
Phone: 813-745-4673
entissa@moffitt.usf.edu